An advisory panel discussed the Galleri test and voted 7–2 in support. A panel vote is one step in review, not an approval decision.
Reading the Headlines · Sep 23, 2026
At its September 23 meeting, a federal advisory panel considered the Galleri multi-cancer early detection blood test. The panel vote was 7–2, with one abstention, according to the reporting accompanying this card.
The proposed test is meant to complement existing cancer screening for adults aged 50 and older. The panel's recommendation is part of the review process; it does not itself settle whether the test will be authorized. Anyone considering screening choices should discuss them with a qualified clinician.
